TIGENIX SAU has a total of 19 patent applications. It increased the IP activity by 0.0%. Its first patent ever was published in 2006. It filed its patents most often in Japan, EPO (European Patent Office) and United States. Its main competitors in its focus markets pharmaceuticals, biotechnology and medical technology are TIGENIX S A U, SYNOVIS LTD and NEUROTECH USA INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | Japan | 11 | |
#2 | EPO (European Patent Office) | 2 | |
#3 | United States | 2 | |
#4 | China | 1 | |
#5 | United Kingdom | 1 | |
#6 | Singapore | 1 | |
#7 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Medical technology | |
#4 | Measurement | |
#5 | Basic materials chemistry |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Microorganisms | |
#4 | Diagnosis and surgery | |
#5 | Analysing materials | |
#6 | Object sterilising | |
#7 | Preservation of human bodies |
# | Name | Total Patents |
---|---|---|
#1 | Dalemans Wilfried | 5 |
#2 | Lombardo Eleuterio | 4 |
#3 | Manuel Angel Gonzalez De La Pena | 4 |
#4 | Dirk Buescher | 3 |
#5 | Maria Gema Fernandez Miguel | 3 |
#6 | Rosa Ana Garcia Castro | 3 |
#7 | Mariano Garcia Arranz | 3 |
#8 | Dekker Robert | 3 |
#9 | Garcia-Olmo Damian | 3 |
#10 | Olga De La Rosa | 2 |
Publication | Filing date | Title |
---|---|---|
WO2020165152A1 | Cryopreservation of stem cells | |
EP3160481A1 | Mesenchymal stromal cells for treating sepsis | |
JP2015016346A | Injection device |